ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 14 of 46
Up
JMBS 2022, 7(1): 112–118
https://doi.org/10.26693/jmbs07.01.112
Clinical Medicine

Hematological Indicators in Patients with Crisis Ischemic Heart Disease

Kozar V. V. 1, Novikova I. V. 2, Kulakova A. V. 1,2, Yeromenko R. F. 1, Dolzhykova O. V. 1, Brechka N. M. 3
Abstract

The purpose of the study was to investigate and evaluate the data of hematological studies in women and men with ischemic heart disease in critical condition. Materials and methods. The results of examination of 14 patients with ischemic heart disease in critical condition, who will be hospitalized for approximately the same period of time in the intensive care unit of the cardiology department of the Municipal Non-Profit Enterprise of Kharkiv City Council "Regional Clinical Hospital" were included in the study. The patients included 7 women and 7 men aged 38 to 60 years who were diagnosed with acute myocardial infarction at the clinic. Laboratory tests were performed at the time of hospitalization and after 3–4 consecutive days in the dynamics of treatment. Morphological evaluation of blood cells in a blood smear and quantitative indicators were included in hematological examination and were determined on a hematological analyzer ABX MICROS 60 OT (France). Results and discussion. The study found that women had an increase in white blood cell count, hemoglobin concentration an average and mean erythrocyte hemoglobin increases at the time of hospitalization. Increase in the number of leukocytes, decrease in hemoglobin and erythrocytes were found in men. On the dynamics of treatment for 3–4 days, the number of leukocytes in women decreased by almost 1.4 times compared to the data time of hospitalization, while in men — only by 1.02 time, 4 out of 7 men even had an increase in leukocytes. The number of erythrocytes, the concentration of hemoglobin in females has changed a lot, and the MCN indicator has dropped to the same level. The number of erythrocytes and hemoglobin concentration almost did not change in men. Conclusion. In women and men with ischemic heart disease in a critical condition some differences in hematological parameters were noted. It must be taken into account based on the principles of 4P therapy. Inflammation, according to leukocytosis, was higher in women at the time of hospitalization, but after treatment the reduction was more significant than in men. The numbers of erythrocytes, hemoglobin concentration, erythrocyte index of mean erythrocyte hemoglobin were slightly higher in women than in men. These indicators were mostly reduced in men. Received results show that an increase in procoagulant status was more characteristic for women, and the development of an anemic state was more typical for men. On days 3–4, complete recovery of hematological parameters have not yet occurred, the exception was a slight decrease in the number of leukocytes. This indicates a decrease in the intensity of inflammation. Prospects of further researches. The obtained results of hematological studies of critically condition of patients with ischemic heart disease confirm the importance of laboratory tests for the timely identification of the risk of complications and monitoring the state and prognosis of the disease in men and women

Keywords: ischemic heart disease, critical condition, myocardial infarction, hematological parameters, men and women

Full text: PDF (Ukr) 280K

References
  1. Sertsevo-sudynni zakhvoriuvannia — holovna prychyna smerti ukraintsiv. Vysnovky z doslidzhennia hlobalnoho tiaharia khvorob u 2019 rotsi. 04.01.2021 [Cardiovascular diseases - the main cause of death of Ukrainians. Conclusions from the study of the global tiagara disease in 2019. 01/04/2021]. Available from: https://phc.org.ua/news/sercevo-sudinni-zakhvoryuvannya-golovna-prichina-smerti-ukrainciv-visnovki-z-doslidzhennya [Ukrainian]
  2. Severino P, D'Amato A, Pucci M, Infusino F, Adamo F, Birtolo LI, et al. Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction. Int J Mol Sci. 2020;21(21):8118. PMID: 33143256. PMCID: PMC7663258. https://doi.org/10.3390/ijms21218118
  3. InanlooRahatloo K, Liang G, Vo D, Ebert A, Nguyen I, Nguyen PK. Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease. PLoS One. 2017;12:e0183874. PMID: 28850583. PMCID: PMC5574577. https://doi.org/10.1371/journal.pone.0183874
  4. Annamaria De Bellis, Giulia De Angelis, Enrico Fabris et al. Gender-related differences in heart failure: beyond the "one-size-fits-all" paradigm. Heart Fail Rev. 2020;25(2):245-255. PMID: 31267323. https://doi.org/10.1007/s10741-019-09824-y.
  5. Lam CSP, Arnott C, Beale AL, Chandramouli C, Hilfiker-Kleiner D, Kaye DM, et al. Sex differences in heart failure. Eur Heart J. 2019;40(47):3859-3868. PMID: 31800034. https://doi.org/10.1093/eurheartj/ehz835
  6. Tillmanns H, Waas W, Voss R, Grempels E, Hölschermann H, Haberbosch W, et al. Gender differences in the outcome of cardiac interventions. Herz. 2005;30(5):375-89. PMID: 16132240. https://doi.org/10.1007/s00059-005-2716-3
  7. Freisinger E, Sehner S, Malyar NM, Suling A, Reinecke H, Wegscheider K. Nationwide Routine‐Data Analysis of Sex Differences in Outcome of Acute Myocardial Infarction. Clin Cardiol. 2018;41(8):1013–1021. PMID: 29667216. PMCID: PMC6489736. https://doi.org/10.1002/clc.22962
  8. Chia S, Nagurney JT, Brown DF, Raffel OC, Bamberg F, Senatore F, et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol. 2009;103(3):333-7. PMID: 19166685. https://doi.org/10.1016/j.amjcard.2008.09.085
  9. Yeh YT, Liu CW, Li AH, Ke SR, Liu YH, Chen KC, et al. Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention An Observational Study. Medicine (Baltimore). 2016;95(7):e2857. PMID: 26886652. PMCID: PMC4998652. https://doi.org/10.1097/MD.0000000000002857
  10. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626–638. PMID: 27546235. https://doi.org/10.1038/nri.2016.90
  11. Horbachova VV, Liashenko AV, Gavrylenko TI, Mhitaryan LS, Voronkov LG. Kliniko-instrumentalna kharakterystyka ta klinichnyi prohnoz u patsiientiv z khronichnoiu sertsevoiu nedostatnistiu i znyzhenoiu fraktsiieiu vykydu livoho shlunochka v zalezhnosti vid naiavnosti ta kharakteru zalizodefitsytnoho stanu [Clinical and instrumental characteristics and clinical prognosis in patients with chronic heart failure and reduced left ventricular ejection fraction depending on the presence and nature of iron deficiency]. Ukrainskyi kardiolohichnyi zhurnal. 2018;5:33-42 [Ukrainian]
  12. Hammadah M, Alkhoder A, Al Mheid I, Wilmot K, Isakadze N, Abdulhadi N, et al. Hemodynamic, catecholamine, vasomotor and vascular responses: Determinants of myocardial ischemia during mental stress. Int J Cardiol. 2017;243:47-53. PMID: 28571621. PMCID: PMC5532063. https://doi.org/10.1016/j.ijcard.2017.05.093
  13. Bugiardini R, Manfrini O, Cenko E. Female sex as a biological variable: A review on younger patients with acute coronary syndrome. Trends Cardiovasc Med. 2019;29(1):50-55. PMID: 29941243. https://doi.org/10.1016/j.tcm.2018.06.002
  14. Kanic V, Kompara G, Vollrath M, Suran D, Kanic Z. Sex-Related Anemia Contributes to Disparities in Outcome of Patients Younger Than 60 Years with ST-Elevation Myocardial Infarction. J Womens Health (Larchmt). 2018;27(6):755-760. PMID: 29377747. https://doi.org/10.1089/jwh.2017.6644